XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
Revenue $ 33,919 $ 38,461
Operating expenses:    
Sales and marketing 1,751 1,219
Research and development 281 1,380
General and administrative 13,960 11,442
Total operating expenses 15,992 14,041
Operating income 17,927 24,420
Interest and other income (loss), net 24,988 2,545
Income before benefit from (provision for) income taxes 42,915 26,965
Benefit from (provision for) income taxes (8,939) 3,699
Net income $ 33,976 $ 30,664
Basic net income per share (in dollars per share) $ 1.05 $ 0.92
Shares used in calculating basic net income per share (in shares) 32,214 33,280
Diluted net income per share (in dollars per share) $ 1.04 $ 0.92
Shares used in calculating diluted net income per share (in shares) 32,536 33,508
Deferred gains (losses) on available-for-sale marketable debt securities $ 1,200 $ (944)
Realized gains on available-for-sale marketable debt securities reclassified to net income 300 734
Total comprehensive income 35,476 30,454
Accumulated Deficit    
Operating expenses:    
Net income 33,976 30,664
Royalty and license    
Revenues:    
Revenue 33,781 38,178
Development, services, and other    
Revenues:    
Revenue $ 138 $ 283